Healthcare
Live Price
Offline$1.74
+1.16% today
1Y Change
-9.14%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 240 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Seer, Inc. (SEER) is a Healthcare stock with a market cap of $110.00M and listed on NASDAQ. The stock last traded around $1.74 and down 9.1% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of +18.9%, EPS growth of +7.9%, a dividend yield of 0.0%. What stands out right now is revenue +18.9%, EPS +7.9%, free cash flow +6.9% with operating margin -470.5% and ROIC -27.6%. Valuation sits in the middle of the pack at price/sales 6.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SEER price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SEER
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SEER Max Drawdown
-29.96%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SEER and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$6.4M
-56.5% YoY
FY Net Income
-$71.2M
+23.4% YoY
Free Cash Flow
-$53.3M
+25.0% YoY
Revenue Growth
+18.9%
EPS Growth
+7.9%
Gross Margin
51.1%
Net Margin
-444.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 17M | 14M | 15M | 15M | 6M |
| Gross Profit | 8M | 7M | 1M | 384K | -374K |
| Operating Income | -78M | -100M | -105M | -98M | -72M |
| EBITDA | -66M | -94M | -81M | -87M | -68M |
| Net Income | -74M | -87M | -86M | -93M | -71M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 47M | 41M | 32M | 53M | 233M |
| Total Assets | 296M | 367M | 436M | 488M | 539M |
| Total Liabilities | 37M | 39M | 39M | 41M | 36M |
| Shareholder Equity | 259M | 328M | 397M | 447M | 503M |
| Total Debt | 24M | 26M | 28M | 30M | 23M |
| Net Debt | -24M | -15M | -4M | -23M | -209M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
46M
+23.7% YoY
Capital Expenditures
7M
+32.6% YoY
Free Cash Flow
53M
+25.0% YoY
Key ratios
Gross Margin
51.1%
Operating Margin
-470.5%
Net Margin
-444.0%
ROE
-26.0%
Debt / Equity
0.09x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.